Human -adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for dia...

Full description

Saved in:
Bibliographic Details
Main Authors LI JOANA X, LEE ERNESTINE A, BECHA SHANYA D, FORSYTHE IAN J, ISON CRAIG H, RICHARDSON THOMAS W, HAFALIA APRIL J. A, YUE HENRY, THORNTON MICHAEL B, SWARNAKAR ANITA, BAUGHN MARIAH R, GANDHI AMEENA R, LU YAN, YAO MONIQUE G, MARQUIS JOSEPH P, LUO WEN, ELLIOTT VICKI S, TRAN UYEN K, LEE SOO YEUN, WILSON AMY D, NGUYEN DANNIEL B, GURURAJAN RAJAGOPAL, CHAWLA-WALIA NARINDER K, KHARE REENA, JIN PEI
Format Patent
LanguageEnglish
Published 11.09.2012
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.
Bibliography:Application Number: US20100923407